Tango Therapeutics to Discuss Innovations at Healthcare Event
Tango Therapeutics, Inc. (NASDAQ: TNGX) is set to take part in a significant healthcare conference that aims to bring together key stakeholders in the medical and biotech industries. Dr. Adam Crystal, who serves as the President of Research & Development for the company, will engage in a lively fireside chat. This event, organized by Piper Sandler, promises to be a vital platform for discussing the latest advancements and research developments in healthcare.
Details of the Event
The fireside chat at the Piper Sandler 37th Annual Healthcare Conference is scheduled for Wednesday, December 3 at 1:30 PM ET. Attendees can tune into the live webcast, which will be available under the "Events & Presentations" tab on the company's website. For those who miss the live event, a replay will be accessible for 90 days afterward, allowing stakeholders to catch up on the insights shared during the session.
About Tango Therapeutics
Tango Therapeutics is a cutting-edge biotechnology company dedicated to discovering novel drug targets with a mission to provide the next generation of precision medicine to combat cancer. The company utilizes the genetic principle of synthetic lethality, which focuses on designing therapies that specifically target critical factors in cancer progression. This innovative approach positions Tango Therapeutics at the forefront of personalized cancer treatment.
Company's Focus on Cancer Treatment
The vision of Tango Therapeutics revolves around patient-centric solutions, where every discovery emphasizes improving patient outcomes. By leveraging advancements in genomics and biotechnology, they aim to develop therapies capable of addressing various forms of cancer. Their commitment to research and innovation aligns with the growing demand for effective cancer treatments in today’s healthcare landscape.
Connect with Tango Therapeutics
For those interested in learning more about the company and its innovative therapeutic developments, please visit their official website. Tango Therapeutics is keen on maintaining an open dialogue with media and investors alike. They encourage inquiries and discussions regarding their ongoing research and future projects.
Contact Information:
For investor relations inquiries, you can reach out to Elizabeth Hickin via email at IR@tangotx.com. For media inquiries, please contact media@tangotx.com.
Frequently Asked Questions
What is the main event that Tango Therapeutics will participate in?
Tango Therapeutics will participate in the Piper Sandler 37th Annual Healthcare Conference, featuring a chat with their President of Research & Development.
How can I watch the presentation from Tango Therapeutics?
The presentation will be available as a live webcast on the company's Investors page and a replay will be accessible for 90 days post-event.
What is the focus area of Tango Therapeutics?
The company concentrates on developing precision medicine targeted at cancer treatment using synthetic lethality principles in their research approach.
Where can I find more information about Tango Therapeutics?
Additional insights about the company, its research, and progress can be found on their official website.
Who can I contact for investor relations at Tango Therapeutics?
Elizabeth Hickin manages investor relations and can be contacted via email for inquiries related to the company's developments.
